CollPlant Biotechnologies Ltd Form SCHEDULE 13D/A — Oct 8, 2026
Ami Sagy filed Amendment No. 5 to his Schedule 13D on CollPlant Biotechnologies, reporting beneficial ownership of 163,709 ordinary shares, or approximately 5.7% of the class. His percentage decreased solely because the issuer issued new shares since Amendment No. 4 in November 2025; he bought or sold nothing.
Key figures
- Shares Owned
- 163709
- Percent Owned
- 5.7%
- Reverse Split Ratio
- 1-for-10
- Shares Outstanding Basis
- 2866715
- Reverse Split Effective Date
- 2026-09-04
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.